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Background: The increasing number of multidrug-resistant bacteria and the fact of antibiotic resistance is
leading to a continuous need for discovering alternative treatments against infections, e.g. in the case of
respiratory tract diseases. Essential oils (EOs), because of their volatility, can easily reach both the upper and
lower parts of the respiratory tract via inhalation. Therefore, the aim of the present study was the antibacterial
evaluation of clove, cinnamon bark, eucalyptus, thyme, scots pine, peppermint, and citronella EOs against
respiratory tract pathogens such as Streptococcus pneumoniae, S. mutans, S. pyogenes, Haemophilus influenzae,
H. parainfluenzae, and Moraxella catarrhalis. Furthermore, we wanted to compare the antibacterial effect of
these EOs in two different test systems to provide data for the development of an appropriate product
formulation.
Methods: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were
determined with in vitro vapor phase test (VPT) and broth macrodilution test (BDT). The chemical and
percentage compositions of the EOs were determined by GC-MS and GC-FID analysis.
Results: Among the EOs, thyme was the most effective against S. mutans (MIC: 0.04 mg/mL in BDT, but
cinnamon bark and clove oils also presented high inhibition in liquid medium with MIC values of 0.06 mg/mL and 0.
1 mg/mL against S. pneumoniae and S. pyogenes, respectively. M. catarrhalis was the most sensitive to thyme
EO (MIC: 0.09 mg/mL). Cinnamon bark EO was the most effective against Haemophilus spp. (MIC: 0.06
mg/mL). In the VPT, cinnamon bark was the most effective oil against all investigated pathogens with MIC values in
the range of 15.62–90 μl/L. Surprisingly, the eucalyptus and scots pine showed weak activity against the test bacteria in
both test systems.
Conclusions: The EO of thyme, clove and cinnamon bark may provide promising antibacterial activity against
respiratory tract pathogens either in liquid medium or in vapor phase. However, their effect is lower than that
of the reference antibiotics. The combination of EOs and antibiotics may be beneficial in the alternative
treatment of respiratory tract diseases. In vivo studies are necessary to calculate the effective dose of EOs in patients
and determine their possible side effects and toxicity.
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Respiratory tract diseases cause significant mortality in
both sexes according to the data of World Health
Organization (WHO) [1]. Moreover, pneumonia was
responsible for 13% of causes of death among
post-neonatal (1–59 month) children in 2012 [2]. Several
microorganisms are responsible for the upper/lower re-
spiratory tract infections (RTIs). However, the number
of studies including respiratory tract bacteria is low.
Among antibiotic-resistant bacteria causing severe
RTIs, this study focuses on the Gram-positive Strepto-
coccus mutans, S. pyogenes, S. pneumoniae, and the
Gram-negative Haemophilus influenzae, H. parain-
fluenzae, and Moraxella catarrhalis. The importance
of the examination of these pathogenic bacteria is not
questionable, because they frequently cause RTIs in
humans.
RTIs include several acute or chronic diseases caused
by viruses and/or bacteria. H. influenzae is responsible
for e.g. epiglottitis. This bacterium together with S.
pneumoniae and M. catarrhalis is able to evoke chronic
bronchitis as well [3]. Among the lower RTIs, pneumo-
nia is a highly dangerous infection, because it can easily
lead to death. There are two major categories of pneu-
monias: community-acquired pneumonia and pneumo-
nia associated with hospital, ventilation or health care.
H. influenzae and M. catarrhalis are common in patients
with community-acquired pneumonia, while S. pneumo-
niae occurs frequently among hospitalized patients [3].
There are a great number of products containing es-
sential oils (EOs) in commercial marketing. However,
EOs are generally applied based upon long-standing use
in the complementary and alternative treatment of di-
verse diseases. Their antimicrobial potential is generally
studied by several in vitro techniques, but mainly liquid
phase is used in these assays instead of vapor phase (VP)
[4]. The commonly used in vitro antimicrobial methods
describe a wide range of assays with different parameters
(agar recipes, incubation time, emulsifiers, microorgan-
isms) [5, 6] so the results from the assays are very differ-
ent and it is difficult to compare them. EOs are
non-water-soluble substances, therefore, the commonly
applied microbiological tests have been optimized to this
condition.
In the case of RTIs, the vapor of EOs can pass into the
airway and make a direct contact with the infected
surface [7]. Therefore, it is worth investigating the anti-
microbial effect of EOs in the VP. Previously, in vitro
assessments of antimicrobial efficacy of EO vapors were
published, however, there is no standardized in vitro VP
method nowadays, and the comparison of the results
of different studies is very difficult or even impossible
[8–10]. The antimicrobial activity of EOs may alter
among different in vitro conditions; therefore, theparallel assessment of this property in two test
systems (liquid medium and VP) should provide more
valuable results and data for development of new
natural products used in the alternative treatment of
RTIs.
Therefore, the aim of the present study was to evaluate
the antibacterial effect of EOs of clove, cinnamon bark,
eucalyptus, thyme, scots pine, peppermint, and citronella
with in vitro broth macrodilution test (BDT) and vapor
phase test (VPT) against pathogens responsible for both
healthcare-associated and community-acquired RTIs. It
should also be mentioned that bacteria included in
this study have not been involved in VPT yet, except
for H. influenzae.Methods
Essential oil samples
The EOs of clove (Syzygium aromaticum (L.) Merill &
Perry, Batch number: E0971/1211), cinnamon bark
(Cinnamomum zeylanicum Nees., Batch number:
A6302/0909), eucalyptus (Eucalyptus globulus Labill.,
Batch number: G1452/1404), thyme (Thymus vulgaris L.,
Batch number: E8392/1308), scots pine (Pinus sylvestris
L., Batch number: G3032/1406), peppermint (Mentha ×
piperita L., Batch number: E7421/1307), and citronella
(Cymbopogon nardus (L.) Rendle, Batch number: G3531/
1407) were obtained from Aromax Ltd. (Budapest,
Hungary).Headspace-solid phase microextraction (sHS-SPME)
conditions
The chemical composition of the EOs was determined
and published by our research group previously in 2016.
The detailed conditions of GC-FID were described there
[11]. Because the vapor of the EOs were used in the
VPT, they were also analysed by sHS-SPME-GC-MS.
sHS-SPME analysis is an effective and flexible analysis
for the rapid characterization of the main components
of the volatile fraction of plants [12]. In the method,
0.1 mL EO was put into a vial (20 mL headspace) sealed
with a silicon/PTFE septum prior to SPME-GC-MS
analysis. Using the static headspace solid phase microex-
traction technique, sample preparation was carried out
with a CTC Combi PAL (CTC Analytics AG, Zwingen,
Switzerland) automatic multipurpose sampler using a
65 μM StableFlex polydimethyl siloxane/divinyl benzene
(PDMS/DVB) SPME fibre (Supelco, Bellefonte, PA,
USA). After an incubation period of 5 min at 40 °C,
extraction was performed by exposing the fibre to the
headspace of a 20 mL vial containing the EO sample for
10 min at 40 °C. The fibre was then immediately trans-
ferred to the injector port of the GC-MS and desorbed
for 1 min at 250 °C. The SPME fibre was cleaned and
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atmosphere at 250 °C for 15 min.
GC-MS conditions
The analyses were carried out with an Agilent
6890 N/5973 N GC-MSD (Santa Clara, CA, USA)
system equipped with an Agilent SLB-5MS capillary
column (30 m × 250 μm× 0.25 μm). The GC oven
temperature was programmed to increase from 60 °C
(3 min isothermal) to 250 °C at 8 °C/min (1 min iso-
thermal). High purity helium was used as carrier gas
at 1.0 mL/min (37 cm/s) in constant flow mode. The
injector temperature was 250 °C. The split ratio was
1:50. The mass selective detector was equipped with a
quadrupole mass analyser and it was operated in
electron ionization mode at 70 eV in full scan mode
(41–500 amu at 3.2 scan/s). The data were evaluated
using MSD ChemStation D.02.00.275 software (Agilent).
The identification of the compounds was carried out by
comparing retention times, linear retention indexes and
recorded spectra with the data of authentic standards, and
the NIST 2.0 library was also consulted.
Antimicrobial assays and chemicals
For the detection of antibacterial character of EOs, BDT
and VPT were performed. The effect of EOs was also
compared to the activity of standard antibiotics:
imipenem (Fresenius Kabi, Hungary), amoxicillin/clavu-
lanic acid (Richter Gedeon, Hungary), and amikacin
(Lisapharma S.p.A., Italy). In VPT, we especially focused
on the antibacterial effect of EO’ vapor. As solvent,
absolute ethanol was obtained from Molar Chemicals
Ltd. (Halásztelek, Hungary). The emulsifiers (Polysorbate
80, DMSO) were purchased from Reanal Ltd. (Budapest,
Hungary). Mueller-Hinton agar, Haemophilus test
medium base, and Haemophilus test supplement were
purchased from Oxoid Ltd. (London, UK).
Bacterial strains
The tests were performed against six bacterial strains
including the most frequent respiratory tract pathogens.
Gram-positive bacteria were Streptococcus pneumoniae
(DSM 20566), S. mutans (DSM 20533), and S. pyogenes
(116). Gram-negative strains included Haemophilus
influenzae (DSM 4690), H. parainfluenzae (DSM 8978),
and Moraxella catarrhalis (DSM 9143). S. pyogenes was
isolated from blood cultures, it was used from the
culture collection of the Department of Medical Micro-
biology and Immunology, Medical School, University of
Pécs, Pécs, Hungary. All the other strains were obtained
from the German Culture Collection (Braunschweig,
Germany). Test microorganisms were maintained on 5%
sheep blood agar or chocolate agar at 37 °C at the
Department of Medical Microbiology and Immunology,University of Pécs (Pécs, Hungary). Antibiotic suscepti-
bility of bacteria was tested by disc diffusion method
according to the guidelines of the Manual of Clinical
Microbiology [13]. To avoid the contamination of the
test materials, EOs were filtered through a hydrophilic
polyvinylidene fluoride (PVDF) membrane (Millex-GV
filter, 0.22 μm, Millipore, Ireland) before the microbio-
logical assays. The filtration did not modify the chemical
composition of the EOs.
Broth macrodilution test (BDT)
The experiments were based on the recommendations
of the Manual of Clinical Microbiology associated with
modifications published before [11, 13]. From each EO,
5% emulsions were made with either 0.2% of Polysorbate
80 or DMSO. After this, a serial twofold dilution was
prepared from 50 to 0.0075 μL/mL. As control of the
bacterial growth, neither an EO nor a detergent was
added to the tubes. Test media containing 0.2% of
Polysorbate 80 or DMSO were also used separately as
emulsifier controls. DMSO was applied only in the case
of M. catarrhalis, considering that this bacterium cannot
tolerate Polysorbate 80. In the case of Haemophilus spp.,
we used Haemophilus test medium which consisted of
15 μg/mL hematin and NAD and 5% of yeast extract
per mL. For the dilution series of antibiotics, a deter-
gent was not used. 10 μL of an overnight bacterial
culture (~ 4 × 107 cells/mL) were added to each tube
and incubated at 37 °C for 24 h. Then, in the case of
Streptococci and M. catarrhalis, the tubes were plated
out on 5% sheep blood agar and incubated again for
48 h. Chocolate agar was used for Haemophilus spp.
The number of bacterial colonies was compared to
the controls and then the values of the minimum
bactericidal concentrations (MBC) and minimum in-
hibitory concentrations (MIC) were determined. The
MBC is the lowest concentration of an antibacterial
agent able to completely inhibit the growth of col-
onies. The MIC value is the concentration that could
reduce the visible growth of bacteria in comparison
with the controls. All tests were carried out in tripli-
cate and under aerobic conditions.
Vapor phase test (VPT)
The in vitro VPT were based on the method described
by Kloucek et al. [14] with modifications of our previ-
ously published observations [11]. The test system was
developed in a four-section Petri dish (PD, diameter
90 mm, VWR, Debrecen, Hungary) containing 5 ml of
5% sheep blood agar in the case of Streptococci and M.
catarrhalis. Haemophilus spp. required chocolate agar
with 15 μg/mL NAD supplementation. Test medium
was not added into the upper lid of the PD. All bacteria
were grown in solid test medium at 37 °C for 24 h
Table 1 Percentage composition of EOs by sHS-SPME-GC-MS
analysis
Component RI Percentage of compounds (%)
1 2 3 4 5 6 7
α-Pinene 939 1.1 – 1.0 – 5.7 1.4 26.1
Camphene 951 – – 2.2 – – – 7.9
β-Pinene 978 – – – – 1.0 – 18.0
β-Myrcene 992 1.7 – 1.9 – – – –
α-Phellandrene 1007 – – – – – 1.2 –
α-Terpinene 1017 – – 1.9 – – – –
p-Cymene 1026 – – 27.9 – 6.1 – 3.2
δ-3-Carene 1031 – – – – – – 14.4
Limonene 1044 – 12.8 – – 8.2 – 17.0
1,8-Cineole 1046 17.4 – 3.7 – 11.1 91.0 –
γ-Terpinene 1060 – – 6.5 – – 4.4 3.2
Terpinolene 1093 3.3
Linalool 1104 – 1.0 3.5 – 6.7 – –
Isopulegol 1150 1.1 1.0 – – – – –
Citronellal 1153 – 42.3 – – – – –
Menthone 1156 19.8 – – – – – –
Isomenthone 1159 11.6 – – – – – –
Anethole 1171 – – – – 3.3 – –
Menthol 1172 27.2 – – – – – –
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in sterile 0.9% saline to 105 CFU/mL. Then three
sections of the PD were inoculated with 20 μL of the
selected bacterial suspensions. Different strains were
spread into each section. The fourth compartment was
left uninoculated as contamination control. Each EO
sample was diluted with absolute ethanol (stock
solutions: 0.5–195 μL/mL). 500 μL of stock solution
was distributed on the surface of a sterile filter paper
disc (thickness 0.18 mm, diameter 84 mm,
Albet-Hahnemühle, Germany). The disc was placed
on the separating wall of the PD after solvent evapor-
ation. Therefore, there was approximately 2 mm
distance between the disc and the inoculated agar
surface. PDs were hermetically closed with Parafilm
adhesive tape (Sigma Aldrich Ltd., Budapest,
Hungary) to avoid the evaporation, and they were
incubated at 37 °C for 48 h. After incubation, filter
papers were removed and MIC values were deter-
mined. The MIC is the lowest concentration of an
EO (expressed as μL of EO/free atmosphere above
the growing microorganism) which can absolutely
inhibit the visible growth of the bacteria. Filter paper
discs containing absolute ethanol or left untreated
were used as solvent and growth controls. All tests
were carried out in triplicate.Isomenthol 1183 3.7 – – – – – –
α-Terpineol 1190 – 2.2 – 1.3
Pulegone 1215 1.9 – – – – – –
Citronellol 1226 – 8.9 – – – – –
Nerol 1230 – 12.9 – – – – –
trans-Cinnamaldehyde 1266 – – – – 45.9 – –
Bornyl acetate 1289 – – – – – – 4.2
Thymol 1297 – – 46.1 – – – –
Isomenthyl acetate 1305 6.6 – – – – – –
Citronellyl acetate 1353 – 4.6 – – – – –
Neryl acetate 1365 – 3.5 – – – – –
Eugenol 1373 – – – 66.9 1.4 – –
β-Elemene 1394 – 3.0 – – – – –
β-Caryophyllene 1417 1.3 – 2.3 26.5 5.0 – –
Cinnamyl acetate 1446 – – – – 1.9 – –
α-Humulene 1452 – – – 6.0 – – –
β-Cadinene 1473 – 2.6 – – – – –
β-Muurolene 1493 – 1.5 – – – – –
Total: 93.4 94.1 97.0 99.4 98.5 98.0 98.6
Table 1 shows the average content of volatile compounds which occurred in
the EOs in more than 1% from 3 parallel measurements. The standard
deviations (SD) were below 4.5%. 1. peppermint, 2. citronella, 3. thyme, 4.
clove, 5. cinnamon bark, 6. eucalyptus, 7. scots pine. RI: Retention Index based
on a homologous series of normal alkanes.Results
Headspace-solid phase microextraction - gas
chromatographic mass spectrometry
(HS-SPME – GC-MS) analysis
Chemical analyses of EOs were performed by GC-MS
techniques. Identified compounds and percentage
evaluation of the volatiles are shown in Table 1. In
all samples, the amount of the detected components
was above 93%. In accordance with the literature and
our previous observations, the main volatiles of the
headspace of cinnamon bark, eucalyptus, thyme,
peppermint, and clove oil were trans-cinnamaldehyde
(45.9%), 1,8-cineole (91.0%), thymol (46.1%), menthol
(27.2%), and eugenol (66.9%), respectively. Beside the
main constituents, γ-terpinene (3.2–6.5%), p-cymene
(3.2–27.9%), menthone (19.8%), and β-caryophyllene
(1.3–26.5%) were determined as minor components
in the above mentioned EOs. In citronella oil, citro-
nellal (42.3%), limonene (12.8%), and nerol (12.9%)
were dominant. Scots pine oil contained α-pinene in
higher amount (26.1%), but β-pinene (18.0%) and
limonene (17.0%) were also detected in lower
concentrations.
On the whole, we presume that the above mentioned
components play the main role in the antibacterial
activity of EOs in VP.
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This method allowed us to detect the antibacterial activ-
ity of EOs in liquid media. MIC and MBC values of EOs
were summarized in Tables 2 and 3. MIC values of
general antibiotics are expressed in μg/mL in Table 4.
Cinnamon bark, clove, citronella, and thyme presented
the most potent inhibition against both Gram-negative
and Gram-positive pathogens. The least sensitive
strain to cinnamon and thyme was S. pyogenes (MIC:
0.41–0.43 mg/mL), while clove produced the lowest
MIC value against this pathogen (MIC: 0.1 mg/mL).
Among our tested materials thyme oil showed the
most potent activity (MIC: 0.04 mg/mL) against S.
mutans, which was followed by citronella, cinnamon
bark, and clove. Citronella oil produced the lowest
MIC value against S. pneumoniae. Peppermint pre-
sented inhibition against Streptococcus spp. in higher
concentrations with MIC values in the range of 0.35–
0.70 mg/mL.
In the case of Haemophilus spp., cinnamon bark was
the most effective (MIC: 0.06 mg/mL) oil, which was
followed by thyme, peppermint, and clove. We observed
that H. influenzae and H. parainfluenzae were similarly
sensitive to these EOs, besides, H. parainfluenzae
showed an increased sensitivity to citronella, scots pine,
and eucalyptus oil. In lower amount (MIC: 0.34 mg/mL),
scots pine also showed activity against M. catarrhalis. In
general, it has been observed that eucalyptus showed
activity only in higher concentrations (MIC: 0.7–
2.82 mg/mL). Scots pine oil was active mostly in the
case of our Gram-negative strains. In comparison with
antibiotics, EOs produced inhibition only in higher con-
centrations. We must note that the effect of detergents
did not influence our results.
Antibacterial activity in vapor phase (VP)
Due to the absence of direct contact between the
pathogen and EO, this method allows us to detect the
antimicrobial potency of volatile components exclu-
sively. As a result, MIC values were calculated and sum-
marized in Table 5. They were determined consideringTable 2 Antibacterial activity of EOs against Streptococcus spp. by b
Essential oil S. pyogenes
MIC MBC
Cinnamon bark 0.41 0.81
Thyme 0.43 0.87
Clove 0.10 0.20
Peppermint 0.35 0.70
Citronella 0.17 0.34
Eucalyptus 2.82 5.64
Scots pine 1.35 2.71
MIC minimum inhibitory concentration, MBC minimum bactericidal concentration (in mthe amount of EOs and the free airspace (L) in the Petri
dish. As control, absolute ethanol did not show any anti-
bacterial effect. Among the EOs, cinnamon bark was the
most effective against all investigated pathogens with
MIC values in the range of 15.62–90 μL/L. Above
90 μL/L, thyme oil effectively inhibited the bacterial
growth of Gram-positive pathogens. Besides, thyme vol-
atiles also showed potent inhibition against Haemophilus
spp. and M. catarrhalis. In the case of peppermint and
citronella oils, moderate activities were detected against
Gram-negative strains (MIC: 31.25–75 μL/L), moreover,
their effectiveness against Streptococcus species was also
observed in higher amounts. In our test system, clove oil
was active only above 90 μL/L. EO of scots pine did not
show any inhibition in VP, except in the case of H.
influenzae. Therefore, we presume that scots pine has
bacteriostatic effect, and its MIC is probably higher than
1500 μL/L. In contrast, vapor of eucalyptus oil effectively
inhibited the growth of Haemophilus spp. and M. catar-
rhalis in higher concentrations (MIC: 125–225 μL/L). In
the case of M. catarrhalis, we found citronella and cin-
namon bark oils equally active, which was followed by
peppermint, thyme, and clove. Among our tested patho-
gens, S. mutans was the least sensitive to EO volatiles, in
lower concentration only cinnamon bark performed
potent inhibition (MIC: 90 μL/L) against this pathogen.
In conclusion, we should highlight that Gram-negative
strains were more sensitive to EO vapors: we detected
higher MIC values against all Gram-positive bacteria.
Discussion
Due to the hydrophobic character of EOs, classical
microbiological tests are not relevant for detection of
the antibacterial activity of these substances, thus, some
modifications and development of new techniques is
essential for this purpose. With BDT, we could detect
the antibacterial effect of EOs in liquid medium; how-
ever, the inhibitory effect of volatiles could be deter-
mined with VPT [10]. The EOs application via
inhalation is becoming more frequent nowadays, espe-
cially in the case of bacterial infections of the respiratoryroth macrodilution
S. pneumoniae S. mutans
MIC MBC MIC MBC
0.06 0.13 0.20 0.41
0.11 0.22 0.04 0.09
0.25 0.50 0.41 0.81
0.35 0.70 0.70 1.39
0.09 0.17 0.17 0.34
1.41 2.81 0.70 1.41
0.68 1.35 1.35 2.71
g/mL)
Table 3 Antibacterial activity of EOs against Haemophilus spp. and M. catarrhalis by broth macrodilution
Essential oil H. influenzae H. parainfluenzae M. catarrhalis
MIC MBC MIC MBC MIC MBC
Cinnamon bark 0.06 0.13 0.06 0.13 0.10 0.20
Thyme 0.11 0.22 0.11 0.22 0.09 0.18
Clove 0.25 0.50 0.25 0.50 0.25 0.50
Peppermint 0.21 0.43 0.21 0.43 0.35 0.70
Citronella 0.21 0.42 0.11 0.21 0.11 0.21
Eucalyptus 1.41 2.81 0.70 1.41 2.81 5.64
Scots pine 1.35 2.70 0.34 0.68 0.34 0.68
MIC minimum inhibitory concentration, MBC minimum bactericidal concentration (in mg/mL)
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circumstances of inhalation; moreover, they usually focus
on the activity of EOs via direct contact. In opposite,
VPT detect the effect of gaseous phase produced by EO
vapor and they can be easily combined with other tech-
niques [8]. It should be highlighted that VPT can also be
adapted to other different pathogens such as fungi and
viruses [15–18]. According to the result of the microbio-
logical assays, cinnamon bark, clove, thyme, peppermint,
and citronella oils showed the most potent activity in
both vapor and liquid systems. Therefore, they could be
promising alternatives to support the current general
treatment of bacterial infections. Their multicomponent
composition gives them benefit in bacterial resistance;
however, it simultaneously creates difficulties in their
standardization and their effects’ proper comparison
[19]. In liquid form, cinnamon bark was the most effect-
ive against S. pneumoniae, while thyme oil showed the
best activity against S. mutans. In the case of S. pyogenes,
clove oil produced the lowest MIC value, which was
followed by citronella. Cinnamon bark and thyme were
equally active against this pathogen, which was in ac-
cordance with previous results [5]. Interestingly, Mulya-
ningsih et al. reported inhibition of S. pyogenes by
eucalyptus fruit oil in lower amount compared to our
MIC values. Because we used EO distilled from the
leaves, we suggest that the difference is probably caused
by the compositions of the eucalyptus oils in the experi-
ments [20]. Parallel to our results, a previous publication
has reported the same inhibitory trend and cited strong
antibacterial character of cinnamon bark and cinnamal-
dehyde against S. mutans [21]. Against this pathogen,Table 4 Antibacterial activity of antibiotics by broth macrodilution
Antibiotic S. pyogenes S. pneumoniae S.
MIC90 MIC M
Amoxicillin/clavulanic acid – – 0.
Imipenem 0.25 0.8 3.
Amikacin – – –
MIC and MIC90: minimum inhibitory concentrations expressed in μg/mLantibiofilm activity of eucalyptus oil was also published
[22]. Between Haemophilus spp., slight differences were
observed between the EOs. Among our test materials,
we detected the best inhibition in the case of cinnamon
bark followed by thyme and clove, which was in accord-
ance with previous observations [23, 24]. H. parainfluen-
zae was more susceptible to citronella, eucalyptus, and
scots pine. However, eucalyptus oil and its vapor was
previously reported as promising solutions against re-
spiratory viruses (e.g. Influenza Virus type A and mumps
virus), their antibacterial value in several studies were
less potent than the antiviral effect [16, 25]. According
to other reports, which support our findings, eucalyptus
oil could be a more potent inhibitor of Haemophilus
species in contrast with S. pneumoniae and S. pyogenes
in liquid phase [5, 25]. M. catarrhalis was completely
inhibited by thyme in low concentration; as well as
cinnamon and citronella showed similar activity against
this pathogen. The same potency was observed previ-
ously by Dorman et al. and Tanaka et al., in addition,
EO components such as cinnamaldehyde, citronellal,
thymol, eugenol, geraniol, limonene; cis/trans citral and
α-terpineole also produced activity in their test systems
[24, 26].
In VPT, Gram-negative pathogens were more sensitive
to the EO treatment compared to Gram-positive bacteria.
This observation was parallel to our experience in liquid
media. Against all Streptococcus species, cinnamon bark
vapor produced the lowest MIC value in the range of
75–90 μL/L. In the case of S. pneumoniae, the same
inhibitory effect was observed than in BDT; however,
we found scots pine vapor less active in gaseousmutans H. influenzae H. parainfluenzae M. catarrhalis
IC90 MIC MIC MIC90
8 – – 0.2
1 – – 0.2
3.1 1.6 –
Table 5 Antibacterial activity of cinnamon bark, thyme, clove, peppermint, citronella, eucalyptus, and scots pine oils by vapor phase test
Essential oil S. pyogenes S. pneumoniae S. mutans H. influenzae H. parainfluenzae M. catarrhalis
MIC
Cinnamon bark 75 75 90 15.62 15.62 25
Thyme 125 90 250 25 31.25 50
Clove 225 150 500 90 150 125
Peppermint 250 90 375 50 75 31.25
Citronella 125 50 250 50 62.5 25
Eucalyptus > 1500 1200 > 1500 125 200 225
Scots pine > 1500 > 1500 > 1500 500 > 1500 > 1500
MIC minimum inhibitory concentration [amount of EO in μL referred to airspace volume (L)]
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and thyme vapor, which was followed by clove and
peppermint. Cinnamon bark volatiles were equally
active against H. influenzae and H. parainfluenzae;
however, slight differences were observed between
these two bacteria considering the activity of thyme,
citronella, and peppermint. Our observations were in
accordance with previous reports [9]. Against the
above mentioned Gram-negative bacteria, clove and
eucalyptus oil performed inhibition only in relatively
high concentrations (MIC: 90–200 μL/L). Houdkova
et al. reported moderate activity of cinnamaldehyde
and eugenol against H. influenzae; surprisingly, they
did not report any differences between the activity of
vapor and liquid form of these components [27].
M. catarrhalis was equally sensitive to the vapor of
citronella and cinnamon bark; in contrast, clove and
eucalyptus produced inhibition only in higher concentra-
tions against this pathogen. Except in the case of H.
influenzae, scots pine vapor did not manage proper
inhibition below 1500 μL/L.
Table 6 summarizes the most potent EOs in liquid and
vapor phase with MIC values below 0.5 mg/mL or
100 μL/L. In conclusion, we must highlight cinnamon
bark as the most active EO in both in vitro systems.
Besides, thyme, citronella, and peppermint oil and vaporTable 6 Comparison of antibacterial activity of EOs in liquid
and vapor phase
Essential oil Liquid phase Vapor phase
Cinnamon bark 1, 2, 3, 4, 5, 6 1, 2, 3, 4, 5, 6
Thyme 1, 2, 3, 4, 5, 6 2, 4, 5, 6
Clove 1, 2, 3, 4, 5, 6 4
Peppermint 1, 2, 4, 5, 6 2, 4, 5, 6
Citronella 1, 2, 3, 4, 5, 6 2, 4, 5, 6
Eucalyptus – –
Scots Pine 5, 6 –
EOs were highlighted, if the MIC values were lower than 0.5 mg/mL or 100 μL/L.
1: S. pyogenes 2: S. pneumoniae, 3: S. mutans, 4: H. influenzae, 5: H. parainfluenzae,
6: M. catarrhalisalso had strong antibacterial effect. At lower concentra-
tions, clove oil was a more potent inhibitor in liquid
phase; in vapor form it showed activity against H.
influenzae only. Unfortunately, eucalyptus oil and its
vapor were only active in higher concentrations.
On the whole, we must emphasize that our EOs
were more potent inhibitors in liquid form which is
probably due to the direct contact with the pathogen.
According to previous publications, EOs could interact
with bacteria in many different ways such as alteration of
the cell morphology, membrane permeability, and inhib-
ition of enzymes [8, 19].
Several studies reported that Gram-positive bacteria
were more sensitive to EOs and their components
[28–30] than Gram-negative bacteria. Interestingly, we
found that Gam-negative pathogens required less EO
for their total inhibition in our both systems. We sug-
gest that this is partly due to the fact that S. mutans
forms biofilm, which enhance the resistance of this
pathogen. Our observation was in correlation with
the results of Inouye et al. [9]. The reason for this
phenomenon is not fully understood; however, the
authors pointed out that the outer membrane of H.
influenzae may have an important function [9]. How-
ever, it should be taken into consideration that due to
their lipophilic character they require effective formu-
lation to achieve the proper activity in the respiratory
tract. Thus, further development of effective and
economical application of EOs’ special devices is in-
dispensable in the future. [31–33].
Conclusions
In the case of EOs, the in vitro antimicrobial assays
should be optimized because of their hydrophobic char-
acter and multicomponent composition. Based on our
results, we suggest that VPT provides the best detection
for the activity of EOs based on gaseous contact.
However, BDT is one of the most suitable direct-contact
assays. On one hand, only the optimized BDT and VPT
are able to provide trustworthy results about the anti-
microbial effect of EOs. On the other hand, the
Ács et al. BMC Complementary and Alternative Medicine  (2018) 18:227 Page 8 of 9evaluation of antibacterial activity it should be taken into
consideration that EOs have different characters in li-
quid form or in VP which results in diverse biological
activity. We conclude that cinnamon bark oil possess
the strongest antibacterial activity against all the re-
spiratory tract pathogens used in our study. On the
whole, it should be highlighted that cinnamon, thyme,
peppermint, and citronella also showed potent anti-
microbial activity in vapor and in liquid form; in con-
trast, clove oil was more potent inhibitor in liquid
phase. Finally, in vitro and clinical studies are also re-
quired to calculate the effective doses of EOs, deter-
mine the interactions between the components and
reveal their toxicity.Acknowledgements
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